Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 25307541)

Published in Fungal Genet Biol on October 13, 2014

Authors

Tejas Bouklas1, Bettina C Fries2

Author Affiliations

1: Department of Medicine (Division of Infectious Diseases), Stony Brook University, Stony Brook, NY, USA.
2: Department of Medicine (Division of Infectious Diseases), Stony Brook University, Stony Brook, NY, USA; Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY, USA. Electronic address: bettina.fries@stonybrookmedicine.edu.

Articles cited by this

High-frequency switching of colony morphology in Candida albicans. Science (1985) 6.34

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol (2006) 5.73

An age-induced switch to a hyper-recombinational state. Science (2003) 3.33

Colony and Antigenic Variation in Klebsiella pneumoniae Types A, B and C. J Bacteriol (1939) 3.16

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med (2007) 2.85

Lessons on longevity from budding yeast. Nature (2010) 2.81

Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life span. J Cell Biol (1994) 2.71

Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell (2006) 2.55

Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog (2010) 2.28

Cell size and growth rate are major determinants of replicative lifespan. Cell Cycle (2011) 2.26

Plant cell-size control: growing by ploidy? Curr Opin Plant Biol (2000) 2.22

Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun (2008) 2.15

Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology (2001) 2.08

Fungal cell gigantism during mammalian infection. PLoS Pathog (2010) 2.04

Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog (2010) 2.04

Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis (1993) 2.03

Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun (2003) 1.89

Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science (2011) 1.87

Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS (2009) 1.85

Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol (2005) 1.80

Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun (1995) 1.70

Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest (2010) 1.67

Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect Immun (1998) 1.63

Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun (1999) 1.60

Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc Natl Acad Sci U S A (1998) 1.58

Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J Clin Microbiol (2005) 1.53

Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol (2008) 1.50

The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol (2003) 1.45

Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell (2007) 1.39

Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol Microbiol (2007) 1.38

Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest (2001) 1.38

Phenotypic switching and filamentation in Candida glabrata. Microbiology (2002) 1.38

Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell (2007) 1.36

Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect Immun (2004) 1.31

Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis (1998) 1.30

Colony variants of Neisseria meningitidis strain 2996 (B:2b:P1.2): influence of class-5 outer membrane proteins and lipopolysaccharides. J Med Microbiol (1985) 1.27

Regulation of chronological aging in Schizosaccharomyces pombe by the protein kinases Pka1 and Sck2. Aging Cell (2006) 1.26

Polarity and cell fate asymmetry in Caulobacter crescentus. Curr Opin Microbiol (2012) 1.24

Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot Cell (2012) 1.24

Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect Immun (2009) 1.18

Chitin scar breaks in aged Saccharomyces cerevisiae. Microbiology (2003) 1.17

Genome-wide identification of conserved longevity genes in yeast and worms. Mech Ageing Dev (2006) 1.13

Quantitative evidence for early life fitness defects from 32 longevity-associated alleles in yeast. Cell Cycle (2011) 1.13

Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis. J Infect Dis (2013) 1.11

Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J Clin Invest (2014) 1.08

Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients. BMC Genomics (2011) 1.06

Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect Immun (2006) 1.05

Fission yeast and other yeasts as emergent models to unravel cellular aging in eukaryotes. J Gerontol A Biol Sci Med Sci (2009) 1.03

Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol (2013) 1.02

Comparative Genomics of Serial Isolates of Cryptococcus neoformans Reveals Gene Associated With Carbon Utilization and Virulence. G3 (Bethesda) (2013) 1.01

Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun (2005) 1.01

Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cell Microbiol (2003) 0.98

Phenotypic switching in Candida glabrata accompanied by changes in expression of genes with deduced functions in copper detoxification and stress. Eukaryot Cell (2005) 0.96

Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa. Microbiology (2003) 0.95

Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis. Eukaryot Cell (2009) 0.94

Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation. Infect Immun (2010) 0.92

Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans. Infect Immun (2008) 0.92

Cell division site placement and asymmetric growth in mycobacteria. PLoS One (2012) 0.91

Candida albicans, a distinctive fungal model for cellular aging study. Aging Cell (2008) 0.91

Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect Immun (2008) 0.90

Genetic Diversity and Genomic Plasticity of Cryptococcus neoformans AD Hybrid Strains. G3 (Bethesda) (2012) 0.89

Hypothesis: cell volume limits cell divisions. Acta Biochim Pol (2006) 0.88

Asymmetric growth and division in Mycobacterium spp.: compensatory mechanisms for non-medial septa. Mol Microbiol (2013) 0.88

Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii. Mycopathologia (2008) 0.88

Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans. FEMS Yeast Res (2006) 0.87

Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infect Immun (2011) 0.87

Genetic analysis of aging in Saccharomyces cerevisiae. Trends Genet (1996) 0.87

Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis. MBio (2013) 0.85

A screen for genes involved in respiration control and longevity in Schizosaccharomyces pombe. Ann N Y Acad Sci (2010) 0.82

Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans. Antimicrob Agents Chemother (2002) 0.81

Balancing stability and flexibility within the genome of the pathogen Cryptococcus neoformans. PLoS Pathog (2013) 0.80

Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis. Future Microbiol (2010) 0.78

Cryptococcus neoformans constitutes an ideal model organism to unravel the contribution of cellular aging to the virulence of chronic infections. Curr Opin Microbiol (2013) 0.76